Nanobac Pharmaceuticals, Incorporated Suite 205 Tampa, Florida 33614Dnaprint Genomics Inc • February 4th, 2008 • Services-commercial physical & biological research
The purpose of this letter is to confirm the recent discussions and to amend our agreement in principle between Nanobac Pharmaceuticals, Incorporated (“Buyer”) and DNA Print Genomics, Inc. (“Seller”) regarding Buyer’s proposal to acquire Seller’s business and related operations (the “Business”) dated January 18, 2008. The following sections are amended:
Nanobac Pharmaceuticals, Incorporated Suite 205 Tampa, Florida 33614Dnaprint Genomics Inc • February 4th, 2008 • Services-commercial physical & biological research • Florida
This proposal is being made as a result of the discussions we have had with you and is based upon the information and documents you have provided to us, as well as the representations that you have made to us. Based thereon, the general terms and conditions upon which Buyer proposes to effect the Acquisition are as follows:
